{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:42:13Z","timestamp":1791916933219,"version":"4.3.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.japh.2024.102185","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T23:18:00Z","timestamp":1720567080000},"page":"102185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous glucagon-like peptide-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine case report"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2719-6277","authenticated-orcid":false,"given":"Lauren","family":"Wilcox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6138-1113","authenticated-orcid":false,"given":"Elizabeth","family":"Van Dril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.japh.2024.102185_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2011.04029.x","article-title":"The interface between thyroid and diabetes mellitus","volume":"75","author":"Duntas","year":"2011","journal-title":"Clin Endocrinol"},{"issue":"3","key":"10.1016\/j.japh.2024.102185_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jdiacomp.2015.12.027","article-title":"Incidence and prevalence of thyroid dysfunction in type 1 diabetes","volume":"30","author":"Nederstigt","year":"2016","journal-title":"J\u00a0Diabet Complications"},{"issue":"4","key":"10.1016\/j.japh.2024.102185_bib3","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1016\/j.dsx.2019.07.020","article-title":"Thyroid dysfunction prevalence and relation to glycemic control in patients with type 2 diabetes mellitus","volume":"13","author":"Elgazar","year":"2019","journal-title":"Diabetes Metab Syndr"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2024.102185_bib4","first-page":"S1","article-title":"Standards of medical care in diabetes - 2024","volume":"47","year":"2023","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.japh.2024.102185_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.eprac.2023.02.001","article-title":"American association of clinical Endocrinology Consensus statement: Comprehensive type 2 diabetes management algorithm- 2023 update","volume":"29","author":"Samson","year":"2023","journal-title":"Endocr Pract"},{"key":"10.1016\/j.japh.2024.102185_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/924168","article-title":"A\u00a0review on the association between glucagon-like peptide-1 receptor agonists and thyroid cancer","volume":"2012","author":"Chiu","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.japh.2024.102185_bib7","series-title":"Victoza (Liraglutide) Injection Package Insert","year":"2023"},{"key":"10.1016\/j.japh.2024.102185_bib8","series-title":"Trulicity (Dulaglutide) Injection Package Insert","year":"2023"},{"key":"10.1016\/j.japh.2024.102185_bib9","series-title":"Byetta (Exenatide) Injection Package Insert","year":"2022"},{"key":"10.1016\/j.japh.2024.102185_bib10","series-title":"Bydureon (Exenatide Extended Release) Injection Package Insert","year":"2023"},{"key":"10.1016\/j.japh.2024.102185_bib11","series-title":"Ozempic (Semaglutide) Injection Package Insert","year":"2023"},{"key":"10.1016\/j.japh.2024.102185_bib12","series-title":"Rybelsus (Semaglutide) Tablets Package Insert","year":"2023"},{"key":"10.1016\/j.japh.2024.102185_bib13","series-title":"Adlyxin (Lixisenatide) Injection Package Insert","year":"2022"},{"key":"10.1016\/j.japh.2024.102185_bib14","series-title":"Levothyroxine [package Insert]","year":"2024"},{"issue":"6","key":"10.1016\/j.japh.2024.102185_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000501895","article-title":"The effect of exenatide on thyroid-stimulating hormone and thyroid volume","volume":"8","author":"Sencar","year":"2019","journal-title":"Eur Thyroid J"},{"issue":"9","key":"10.1016\/j.japh.2024.102185_bib16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1080\/17425255.2021.1955856","volume":"17","author":"Hauge","year":"2021","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1-2","key":"10.1016\/j.japh.2024.102185_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1758-8111.2012.00036.x","article-title":"Effect of weight loss after gastric bypass surgery on thyroid function in euthyroid people with morbid obesity","volume":"2","author":"MacCuish","year":"2012","journal-title":"Clin Obes"},{"issue":"4","key":"10.1016\/j.japh.2024.102185_bib18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/oby.2009.320","article-title":"Weight loss through gastric banding: effects on TSH and thyroid hormones in obese subjects with normal thyroid function","volume":"18","author":"Dall\u2019Asta","year":"2010","journal-title":"Obesity"},{"key":"10.1016\/j.japh.2024.102185_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1333033","article-title":"Total weight loss induces the alteration in thyroid function after bariatric surgery","volume":"15","author":"Tian","year":"2024","journal-title":"Front Endocrinol"},{"issue":"4","key":"10.1016\/j.japh.2024.102185_bib20","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cen.14901","article-title":"The GLP-1 receptor agonist exenatide reduces serum TSH by its effect on body weight in people with type 2 diabetes","volume":"99","author":"Tee","year":"2023","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.japh.2024.102185_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/thy.2017.0380","article-title":"Stable isotope pharmacokinetic studies provide insight into effects of age, sex, and weight on levothyroxine metabolism","volume":"28","author":"Younis","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.japh.2024.102185_bib22","series-title":"Mounjaro (Tirzepatide) Injection Package Insert","year":"2023"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912400205X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912400205X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:07:52Z","timestamp":1736302072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431912400205X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S154431912400205X"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102185","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppressed thyroid stimulating hormone levels after initiation of a subcutaneous glucagon-like peptide-1 receptor agonist in a post-thyroidectomy patient managed with levothyroxine case report","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102185","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Pharmacists Association\u00ae. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102185"}}